Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy.

Science (New York, N.Y.) | Oct 19, 2012

Autism spectrum disorders are a genetically heterogeneous constellation of syndromes characterized by impairments in reciprocal social interaction. Available somatic treatments have limited efficacy. We have identified inactivating mutations in the gene BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase) in consanguineous families with autism, epilepsy, and intellectual disability. The encoded protein is responsible for phosphorylation-mediated inactivation of the E1α subunit of branched-chain ketoacid dehydrogenase (BCKDH). Patients with homozygous BCKDK mutations display reductions in BCKDK messenger RNA and protein, E1α phosphorylation, and plasma branched-chain amino acids. Bckdk knockout mice show abnormal brain amino acid profiles and neurobehavioral deficits that respond to dietary supplementation. Thus, autism presenting with intellectual disability and epilepsy caused by BCKDK mutations represents a potentially treatable syndrome.

Pubmed ID: 22956686 RIS Download

Mesh terms: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | Adolescent | Amino Acids, Branched-Chain | Animals | Arginine | Autistic Disorder | Base Sequence | Brain | Child | Child, Preschool | Diet | Epilepsy | Female | Homozygote | Humans | Intellectual Disability | Male | Mice | Mice, Knockout | Molecular Sequence Data | Mutation | Pedigree | Phosphorylation | Protein Folding | Protein Structure, Tertiary | RNA, Messenger | Young Adult

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, Id: K08 MH087639
  • Agency: NHGRI NIH HHS, Id: U54 HG003067
  • Agency: NINDS NIH HHS, Id: P30NS047101
  • Agency: NINDS NIH HHS, Id: R01NS048453
  • Agency: NINDS NIH HHS, Id: P30 NS047101
  • Agency: NIMH NIH HHS, Id: RC2MH089956
  • Agency: NIMH NIH HHS, Id: R25 MH077823
  • Agency: NIMH NIH HHS, Id: T32MH018268
  • Agency: NHGRI NIH HHS, Id: U54HG003067
  • Agency: NINDS NIH HHS, Id: R01 NS041537
  • Agency: NINDS NIH HHS, Id: R01 NS048453
  • Agency: NIMH NIH HHS, Id: T32 MH018268
  • Agency: NICHD NIH HHS, Id: P01 HD070494
  • Agency: Howard Hughes Medical Institute, Id: K08MH087639
  • Agency: NIMH NIH HHS, Id: P01HD070494
  • Agency: NICHD NIH HHS, Id: RC2 MH089956
  • Agency: NIMH NIH HHS, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.